Many people choose to make changes in the way they live and the products they use. Diet and a reasonable amount of physical activity are two subjects that spring to mind immediately as people focus more on staying healthy. And the diet is changing to a more natural and safe food. Another area of concern for people is the medicine they put into or on their bodies. These traditional substances are used for preventative measures, healing existing health issues, relief from pain and many other health-related issues.
Some companies are taking a new approach providing what health-conscious people are looking for: a natural and safe way to accomplish many of the same health results generally accomplished with traditional western-style medicines. One such organization is working hard to create and distribute alternative healing substances.
CV Sciences, based in San Diego, is an organization founded by a father and son team who believe in the benefits of hemp and the products derived from hemp. They also have faith that hemp can add a boost to the economy as a crop and the industry surrounding that crop. Michael Mona Jr. and his son Michael Mona III were among the first visionaries working to lift the US ban on hemp that has been in place for about three-quarters of a century.
San Diego, like many large cities in California, is at the forefront of the “green movement.” The city offers a variety of marijuana dispensaries where customers can find cutting edge CBD and hemp-based products, and in many cases they can ask questions from highly-trained staff. So it makes sense that a company like CV Sciences would set up shop there.
The structure of CV Sciences consists of two distinct divisions, one focuses on pharmaceuticals and the other on consumer products. A scientific and medical advisory board oversees and supports both divisions. In addition, the organization includes state-of-the-art production facilities. Their mission statement at CV leans strongly forward with the goal of improving the human condition, working with innovations focused on healing people, and the planet.
The pharmaceuticals division is working hard to create a synthetic alternative to cannabidiol. The founders of CV are also diligently pursuing approval from the US Food and Drug Administration for the use of cannabidiol based drugs. This will open opportunities for new medicines. The focus is on CBD serum and CBD oil. The approval will also open new doors for the Consumer Products Division which currently provides botanically-based cannabidiol products available online, at healthcare provider’s offices, and health food stores. These products are available nationally.
One of the more promising products currently under development at CV Science’s recently acquired pre-clinical drug developer, CanX Inc., is chewing gum to help users end their addiction to tobacco, including smokeless products. The gum contains nicotine and synthetic CBD.
The most well-known and best-selling brand available from CV Science is PlusCBD Oil. The cannabidiol based products are all-natural and enjoy a respected reputation for delivering quality results to the consumers who use these products. A wide variety of products fall under the brand and all are currently available in the US, including products manufactured from CBD serum used to provide relief for topical external issues healthcare issues.
Medicine is evolving technologically and some experts are looking to history. Sometimes older natural ways can teach a safer way to heal the human body. And improve human well-being by healing and making the earth more sustainable. CV Sciences is embracing a new way of thinking about the old ways of healing. They are working daily to make medicine safer, easier to use and moving the thinking of experts to the idea of moving innovative methods that add to traditional medicine.
